Aspen Aerogels (NYSE:ASPN) Research Coverage Started at TD Cowen

TD Cowen started coverage on shares of Aspen Aerogels (NYSE:ASPN) in a research note published on Friday morning. The firm issued a buy rating and a $11.00 price objective on the construction company’s stock.

Other research analysts have also issued research reports about the stock. B. Riley decreased their price target on shares of Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a research report on Wednesday, February 19th. Barclays lowered their price objective on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 19th. Canaccord Genuity Group lowered their price objective on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. Craig Hallum lowered their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. Finally, Roth Mkm lowered their price objective on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Aspen Aerogels has an average rating of “Moderate Buy” and an average price target of $19.11.

Aspen Aerogels Trading Up 1.4 %

Aspen Aerogels stock opened at $7.91 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The firm has a market cap of $648.76 million, a price-to-earnings ratio of 49.42 and a beta of 2.28. Aspen Aerogels has a 1 year low of $6.70 and a 1 year high of $33.15. The firm’s 50 day moving average price is $10.70 and its two-hundred day moving average price is $16.75.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, research analysts predict that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors have recently modified their holdings of the stock. Quest Partners LLC boosted its stake in shares of Aspen Aerogels by 263.3% during the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock valued at $205,000 after buying an additional 5,361 shares during the period. Sandia Investment Management LP acquired a new stake in shares of Aspen Aerogels during the 4th quarter valued at $89,000. Mesirow Financial Investment Management Inc. acquired a new stake in shares of Aspen Aerogels during the 3rd quarter valued at $252,000. Kovitz Investment Group Partners LLC acquired a new stake in shares of Aspen Aerogels in the 3rd quarter valued at $263,000. Finally, Morse Asset Management Inc bought a new stake in Aspen Aerogels in the third quarter worth $264,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.